Sign In
Buy BAYRY
$13.89
-0.110 (-0.786%)
At Close: Jul 31, 2026
Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG
11:44am, Thursday, 06'th Nov 2025
LEVERKUSEN, Germany--(BUSINESS WIRE)--The Supervisory Board of Bayer AG has appointed Dr. Judith Hartmann to the company's Board of Management, effective March 1, 2026. She will succeed Wolfgang Nickl
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that data from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented in scientific sessions at the American S
Bayer and Luke Bryan Mark 10 Years of Fighting Hunger with YourUpdateTV
03:19pm, Wednesday, 29'th Oct 2025
The ‘Take Care, Now' Campaign Has Helped Provide 10 Million Meals to Families in Need Through Feeding America The ‘Take Care, Now' Campaign Has Helped Provide 10 Million Meals to Families in Need
US FDA approves Bayer's menopause relief drug
01:36pm, Friday, 24'th Oct 2025
Germany's Bayer said on Friday the U.S. Food and Drug Administration has approved its drug for menopause relief.
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Lynkuet® (elinzanetant) 60mg capsules, the first and only dual neurokinin (NK) targeted
Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?
10:41am, Monday, 13'th Oct 2025
Here is how Bayer Aktiengesellschaft (BAYRY) and Biorestorative Therapies, Inc. (BRTX) have performed compared to their sector so far this year.
BAYRY Begins Phase I Study With KQB548 in KRAS-Mutated Cancers
12:00pm, Thursday, 09'th Oct 2025
Bayer and Kumquat launch a phase I study of KQB548, aiming to target various KRAS G12D-mutated tumors like pancreatic, colorectal and lung cancer.
Why Bayer's Worst Years Might Be The Start Of Its Comeback
05:39am, Thursday, 09'th Oct 2025
Bayer Aktiengesellschaft remains deeply undervalued despite ongoing business struggles and litigation headwinds, with significant upside potential if challenges are resolved. Bayer's Q2 '25 results we
Bayer Reports Positive Data on Cell Therapy for Parkinson's Disease
12:26pm, Wednesday, 08'th Oct 2025
BAYRY's subsidiary BlueRock reports 36-month data showing its Parkinson's therapy bemdaneprocel remains safe and effective in easing motor symptoms.
3 Large Drug Stocks to Watch as Industry Recovers After PFE-Trump Deal
09:46am, Wednesday, 08'th Oct 2025
Pfizer's landmark pricing deal with Trump sparks a pharma rally as J&J, Bayer and Novartis emerge as strong contenders for inclusion in one's portfolio.
Hesperos and Bayer Consumer Health Develop First Human-on-a-Chip® Model of Stress-Induced Cognitive Dysfunction
01:00pm, Tuesday, 07'th Oct 2025
ORLANDO, Fla.--(BUSINESS WIRE)-- #BiotechNews--Hesperos, Inc. (Hesperos), a global leader focused on improving preclinical drug development, food, cosmetic, and chemical testing with its Human-on-a-Ch
Bayer Partners with Cornfed Farms to Create First ForwardFarm in Midwest
10:00am, Tuesday, 07'th Oct 2025
ST. LOUIS--(BUSINESS WIRE)--Bayer is proud to announce that Cornfed Farms, a fourth-generation farm operated by the Mohr family, has been designated as the first Bayer ForwardFarm site in the Midwest
Luke Bryan and Bayer discuss the Take Care, Now campaign With YourUpdateTV
10:16am, Friday, 03'rd Oct 2025
10 Years of Supporting Rural America: Bayer and Luke Bryan Team Up with Feeding America® to Tackle Hunger with “Take Care, Now” Campaign 10 Years of Supporting Rural America: Bayer and Luke Bryan
Best Value Stock to Buy for September 26th
09:26am, Friday, 26'th Sep 2025
BAYRY, CARS and MRX made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 26, 2025.
Bayer Canada Announces New Distribution Partnership for ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in Canada
10:00am, Thursday, 25'th Sep 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Bayer Canada is pleased to announce a new partnership with Mint Pharmaceuticals Inc. for the distribution of ADALAT® XL® 30 mg tablets1 in Canada. This strateg
